Stomach microbe exposure may be linked to more than 1 in 5 bowel cancer cases worldwide
· Medical Xpressedited by Gaby Clark, reviewed by Andrew Zinin
Gaby Clark
Scientific Editor
Meet our editorial team
Behind our editorial process
Andrew Zinin
Chief Editor
Meet our editorial team
Behind our editorial process Editors' notes
This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:
fact-checked
trusted source
proofread
The GIST Add as preferred source
Exposure to the stomach microbe Helicobacter pylori may be associated with more than 1 in 5 cases of colorectal cancer worldwide, suggests an exploratory risk-attribution study published in the journal eGastroenterology.
Those born in more recent decades may be at greater risk of the disease after exposure, the analysis suggests, and high-quality long-term studies are needed to determine whether eradication therapy with antibiotics significantly lowers colorectal cancer risk, the researchers conclude.
Colorectal cancer is the second-leading cause of cancer-related death. In 2022, there were nearly 2 million new cases and 900,000 deaths from the disease worldwide, the researchers note.
H. pylori is categorized as a group 1 (definite) human carcinogen given its established causal association with stomach cancer. But its potential role in colorectal cancer risk remains hotly debated, despite accumulating evidence, they explain.
In a bid to strengthen the evidence base and inform future preventive strategies in countries with a high prevalence of H. pylori infection and limited resources, the researchers set out to estimate the extent to which exposure might be related to the global toll of colorectal cancer cases.
They therefore drew on data from systematic reviews and pooled-data analyses, stratified by various factors, including region, diagnostic method, sex, access to a national colorectal cancer screening program and the use of eradication therapy.
They derived international estimates of colorectal cancer cases from the Global Cancer Observatory (GLOBOCAN) for 2022.
Their analysis revealed that exposure to H. pylori was associated with a 1.6-fold greater risk of colorectal cancer than no exposure.
No statistically significant differences were observed when categorized by sex, age (above and below 60), diagnostic method or the presence of a national colorectal cancer screening program.
In the four observational studies that reported on this, H. pylori eradication therapy was associated with a reduced risk of the disease, but only after 10 years.
Globally, pooled risk estimates from 43 studies (48,694,403 people) indicated that H. pylori exposure might be linked to around 1 in 5 (22%) of colorectal cancer cases.
The estimated proportion attributable to exposure was much lower, however, when restricted to 14 population-based and cohort studies (12%).
When stratified by region and country, the Western Pacific and Mongolia had the highest estimated proportions of cases potentially linked to H. pylori exposure—25% and 36%, respectively—while China had the highest absolute number of cases linked to exposure: 139,619.
This contrasts with similarly high H. pylori prevalence in Africa, Southeast Asia and the Eastern Mediterranean, but comparatively lower estimated proportions of cases attributable to H. pylori exposure.
Exploratory data-pattern analysis suggested that the proportion of colorectal cancers linked to exposure was greater among those born in more recent decades (1960s and 1970s), rising from 9.5% in those born before 1947 to around 10% among those born in 1948–62 and 15% among those born in 1963–77.
The researchers point out that there are many potentially influential risk factors in the development of colorectal cancer, including nonmodifiable ones, such as genetics and age, as well as modifiable ones, such as those related to lifestyle and diet.
Worldwide, these account for a larger estimated proportion of colorectal cancer cases than H. pylori, they add.
"Population-level H. pylori control may help prevent gastric cancer and, if the link with [colorectal cancer] is causal, could reduce [this] burden in high-prevalence areas. However, success depends on local epidemiology, health care capacity and integration with existing [colorectal cancer] screening.
"As with primary gastric cancer prevention, large-scale H. pylori eradication raises concerns about antibiotic stewardship and resistance, and treatment side effects," the researchers highlight.
The findings underscore the importance of well-designed randomized clinical trials and other prospective investigations evaluating the impact of H. pylori and its eradication on [colorectal cancer] risk, as well as potential modifying factors, they conclude.
More information
Global and regional burden of colorectal cancer potentially related to Helicobacter pylori exposure: a risk attribution modelling study, eGastroenterology (2026). DOI: 10.1136/egastro-2026-100436
Key medical concepts
Colorectal CancerHelicobacter pylori
Clinical categories
GastroenterologyCommon illnesses & PreventionInfectious diseases Provided by British Medical Journal Who's behind this story?
Gaby Clark
MA in English, copy editor since 2021 with experience in higher education and health content. Dedicated to trustworthy science news. Full profile →
Andrew Zinin
Master's in physics with research experience. Long-time science news enthusiast. Plays key role in Science X's editorial success. Full profile →
Citation: Stomach microbe exposure may be linked to more than 1 in 5 bowel cancer cases worldwide (2026, September 8) retrieved 9 September 2026 from https://medicalxpress.com/news/2026-09-stomach-microbe-exposure-linked-bowel.html This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.